Moderna stock has rallied by almost 15% over the last week (five trading days), outperforming the S&P 500 which was up by just over 1% over the same period. The rally comes as Moderna's Covid-19 shot saw strong efficacy results (93% to 100%) from clinical trials conducted on children aged...
Moderna stock has rallied by almost 15% over the last week (five trading days), outperforming the S&P 500 which was up by just over 1% over the same period. The rally comes as Moderna's Covid-19 shot saw strong efficacy results (93% to 100%) from clinical trials conducted on children aged...
Share this Article
Recommended